Search Results 7031-7040 of 34502 for oral

  1. RAdiolabeled Perfusion to Identify Coronary Artery Disease Using WAter To Evaluate Responses of Myocardial FLOW (RAPID-WATER-FLOW) - Mayo Clinic

    Participants who are on sildenafil (Viagra) or oral dipyridamole (Persantine, Aggrenox) therapy or on any PDE5 inhibitor (i.e. tadalafil, avanafil ...

  2. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  3. Fransoua F. Her, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    Mock Oral ExaminerUniversity of Wisconsin Hospitals and Clinics. 2021 - present. MemberAmerican Society of Regional Anesthesia and Pain Medicine. 2021 - 2024.

  4. Maria Daniela Hurtado Andrade, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    2025 Research and Innovation Award: Outstanding Oral Abstract PresentMayo Clinic Department of Medicine. 2024. 2024 Clinical Practice Committee Innovation ...

  5. Women's Wellness: Birth control pill benefits, risks and choices - Mayo Clinic News Network

    If you take the birth control pill (oral contraceptive), you're probably happy with its convenience and reliability. Still, you may have questions about how ...

  6. Radicava® (Edaravone) Biomarker Study In Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    However, as observed in prior clinical trials, ALS presentation and progression is extremely heterogeneous among patients. There is therefore an imperious need ...

  7. Tonsil cancer - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Plastic Surgery · Proton Beam Therapy Program ...

  8. Trimethobenzamide (intramuscular route) - Side effects & uses - Mayo Clinic

    Your doctor may only give you a few doses of this medicine until your condition improves, and then may switch you to an oral medicine that works the same way.

  9. A Study of GDC-0199 (ABT-199) Plus MabThera/Rituxan (Rituximab) Compared with Bendamustine Plus MabThera/Rituxan (Rituximab) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

  10. Jaw tumors and cysts - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Oral Cavity Cancer and Reconstruction Clinic in Minnesota · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology ...